A systematic review on low-level light/laser therapy (LLLT) in male pattern hair loss (MPHL) and female pattern hair loss (FPHL) has been performed.
Objectives:
Compare the reported effectiveness of LLLT in MPHL and FPHL with any control, through randomized controlled trials (RCTs) analysis.
Methods:
The protocol was developed in accordance with the Preferred Reporting for Items for Systematic Reviews and Meta-Analyses-Protocols guidelines. A multistep search of the PubMed, MEDLINE, Embase, PreMEDLINE, Ebase, Clinicaltrials.gov, Scopus database, and Cochrane databases has been performed to identify articles on MPHL and/or FPHL treatment with LLLT.
Results:
Of the 298 articles initially identified, 136 articles focusing on MPHL and FPHL were selected and, consequently, only 36 articles focused exclusively on LLLT. Of this amount, 23 articles were clinical trials while 13 articles were systematic reviews. Systematic reviews were excluded, and only seven articles were analyzed as RCTs.
Conclusions:
All the articles selected and analyzed reported a positive effect of LLLT for MPHL and/or FPHL treatment without side effects.
PriceVH.Treatment of hair loss. N Engl J Med. 1999; 341(13):964–973.
3.
GentileP, GarcovichS, BielliA, et al.The effect of platelet-rich plasma in hair regrowth: A randomized placebo-controlled trial. Stem Cells Transl Med. 2015; 4(11):1317–1323.
4.
GentileP, ColeJP, ColeMA, et al.Evaluation of not-activated and activated PRP in hair loss treatment: role of growth factor and cytokine concentrations obtained by different collection systems. Int J Mol Sci. 2017; 18(2):408.
5.
PausR, CotsarelisG. The biology of hair follicles. N Engl J Med. 1999; 341(7):491–497.
6.
JaworskyC, KligmanAM, MurphyGF. Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis. B. J Dermatol. 1992; 127(3):239–246.
7.
CotsarelisG, SunTT, LavkerRM. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell. 1990; 61(7):1329–1337.
8.
GarzaLA, YangC.-C, ZhaoT, et al.Bald scalp in men with androgenetic alopecia retains hair follicle stem cells but lacks CD200-rich and CD34-positive hair follicle progenitor cells. J Clin Investig. 2011; 121(2):613–622.
9.
GentileP, DionisiL, PizzicannellaJ, et al.A randomized blinded retrospective study: the combined use of micro-needling technique, low-level laser therapy and autologous non-activated platelet-rich plasma improves hair re-growth in patients with androgenic alopecia. Expert Opin Biol Ther. 2020; 20(9):1099–1109.
10.
GentileP.Autologous cellular method using micrografts of human adipose tissue derived follicle stem cells in androgenic alopecia. Int J Mol Sci. 2019; 20(14):3446.
11.
GentileP, GarcovichS. Advances in regenerative stem cell therapy in androgenic alopecia and hair loss: wnt pathway, growth-factor, and mesenchymal stem cell signaling impact analysis on cell growth and hair follicle development. Cells. 2019; 8(5):466.
12.
GentileP, ScioliMG, BielliA, et al.Platelet-rich plasma and micrografts enriched with autologous human follicle mesenchymal stem cells improve hair re-growth in androgenetic alopecia. biomolecular pathway analysis and clinical evaluation. Biomedicines. 2019; 7(2):27.
13.
GentileP, GarcovichS. Systematic review of platelet-rich plasma use in androgenetic alopecia compared with Minoxidil®, Finasteride®, and adult stem cell-based therapy. Int J Mol Sci. 2020; 21(8):2702.
14.
MesterE, SzendeB, TotaJ. Effect of laser on hair growth of mice. Kiserl Orvostud. 1967; 19:628–631.
15.
HamblinMR.Photobiomodulation for the management of alopecia: mechanisms of action, patient selection and perspectives. Clin Cosmet Investig Dermatol. 2019; 12:669.
16.
WikramanayakeTC, RodriguezR, ChoudharyS, et al.Effects of the Lexington LaserComb on hair regrowth in the C3H/HeJ mouse model of alopecia areata. Lasers Med Sci. 2012; 27(2):431–436.
17.
MoherD, LiberatiA, TetzlaffJ, et al.The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097.
18.
HigginsJP, AltmanDG, GøtzschePC, et al.The cochrane collaboration's tool for assessing risk of bias in randomized trials. BMJ. 2011; 343:d5928.
WellsGA, SheaB, O'ConnellD, et al. The Newcastle-Ottawa scale for assessing the quality of nonrandomised studies in meta-analyses. 2014. www.ohri.ca/programs/clinical_epidemiology/oxford.asp (Accessed April13, 2021)
22.
DelaneySW, ZhangP. Systematic review of low-level laser therapy for adult androgenic alopecia. J Cosmet Laser Ther. 2018; 20(4):229–236.
23.
AdilA, GodwinM. The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis. J Am Acad Dermatol. 2017; 77(1):136–141.
24.
MellaJM, PerretMC, ManzottiM, et al.Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Arch Dermatol. 2010; 146(10):1141–1150.
25.
GuptaAK, MaysRR, DotzertMS, et al.Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis. J Eur Acad Dermatol Venereol. 2018; 32(12):2112–2125.
26.
FriedmanS, SchnoorP. Novel approach to treating androgenetic alopecia in females with photobiomodulation (low-level laser therapy). Dermatol Surg. 2017; 43(6):856–867.
27.
LanzafameRJ, BlancheRR, ChiacchieriniRP, et al.The growth of human scalp hair in females using visible red light laser and LED sources. Lasers Surg Med. 2014; 46(8):601–607.
28.
LeavittM, CharlesG, HeymanE, et al.HairMax LaserComb® laser phototherapy device in the treatment of male androgenetic alopecia. Clin Drug Investig. 2009; 29(5):283–292.
29.
LanzafameRJ, BlancheRR, BodianAB, et al.The growth of human scalp hair mediated by visible red light laser and LED sources in males. Lasers Surg Med. 2013; 45(8):487–495.
30.
KimH, ChoiJW, KimJY, et al.Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device-controlled multicenter trial. Dermatol Surg. 2013; 39(8):1177–1183.
31.
JimenezJJ, WikramanayakeTC, BergfeldW, et al.Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device controlled, double-blind study. Am J Clin Dermatol. 2014; 15(2):115–127.
32.
Mai-Yi FanS, ChengYP, LeeMY, et al.Efficacy and safety of a low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, self-comparison, sham device-controlled trial. Dermatol Surg. 2018; 44(11):1411–1420.
33.
SatinoJL, MarkouM. Hair regrowth and increased hair tensile strength using the HairMax LaserComb for low-level laser therapy. Int J Cosmet Surg Aesthetic Dermatol. 2003; 5(2):113–117.
34.
MunckA, GavazzoniMF, TrüebRM. Use of low-level laser therapy as monotherapy or concomitant therapy for male and female androgenetic alopecia. Int J Trichology. 2014; 6(2):45–49.
35.
EsmatSM, HegazyRA, GawdatHI, et al.Low-level light-minoxidil 5% combination versus either therapeutic modality alone in management of female patterned hair loss: a randomized controlled study. Lasers Surg Med. 2017; 49(9):835–843.
MoscaRC, OngAA, AlbashaO, et al.Photobiomodulation therapy for wound care: a potent, noninvasive, photoceutical approach. Adv Skin Wound Care. 2019; 32(4):157–167.
38.
SuchonwanitP, ChalermrojN, KhunkhetS. Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled trial. Lasers Med Sci. 2019; 34(6):1107–1114.
39.
KaruT, KalendoG, LetokhovV, et al.Biostimulation of HeLa cells by low-intensity visible light. Il Nuovo Cimento D. 1982; 1(6):828–840.
40.
HuangY-Y, ChenAC-H, CarrollJD, et al.Biphasic dose response in low level light therapy. Dose-response. 2009; 7(4):358–383.
41.
RobertsJL, FiedlerV, Imperato-McGinleyJ, et al.Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol. 1999; 41(4):555–563.
42.
OlsenEA, DunlapFE, FunicellaT, et al.A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002; 47(3):377–385.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
